Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. [electronic resource]
Producer: 20050314Description: 957-66 p. digitalISSN:- 0008-5472
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Becaplermin
- Benzimidazoles -- pharmacology
- Cell Growth Processes -- drug effects
- Female
- Glioblastoma -- blood supply
- Humans
- Inhibitory Concentration 50
- Mice
- Mice, Nude
- Neovascularization, Pathologic -- drug therapy
- Paclitaxel -- administration & dosage
- Phosphorylation
- Platelet-Derived Growth Factor -- antagonists & inhibitors
- Protein Kinase Inhibitors -- administration & dosage
- Proto-Oncogene Proteins c-sis
- Quinolines -- pharmacology
- Rats
- Receptor, Platelet-Derived Growth Factor alpha -- antagonists & inhibitors
- Receptor, Platelet-Derived Growth Factor beta -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.